Miguel Villegas-Chiroque
Miguel Villegas-Chiroque has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Franklin Rómulo Aguilar-Gamboa
Laboratorio de virología e inmunología, dirección de investigación, Hospital Regional Lambayeque, Chiclayo, Perú
2 shared publications - Alejandro Llanos-Cuentas
Instituto de Medicina Tropical “Alexander von Humboldt”, Universidad Peruana Cayetano Heredia, Lima, Peru
1 shared publication Andrea Farnham
Swiss Tropical and Public Health Institute, Allschwil, Switzerland; University of Basel, Basel, Switzerland
1 shared publication- Claudia R. Rondon
Instituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Peru
1 shared publication Coralith Garcia
Instituto de Medicina Tropical Alexander von Humboldt - Universidad Peruana Cayetano Heredia, Lima, Peru; Hospital Cayetano Heredia, Lima, Peru
1 shared publication- Dennis Cubas-Alarcon
Microbiology Laboratory, Hospital Regional Docente Belén, Lambayeque, Peru
1 shared publication
Latest Publications
- Open Access
- 27 March 2025
- Published by Hospital Regional Lambayeque in Revista Experiencia en Medicina del Hospital Regional Lambayeque
- Vol. 11 (1)
Meningoencefalitis por Herpesvirus Humano 6 (HHV-6) en un niño inmunocompetente de 2 años: Reporte de caso
A clinical case is presented of a 2-year and 5-month-old child who was admitted to the Hospital Regional Lambayeque in Chiclayo, Peru, with an initial diagnosis of status epilepticus, moderate dehydration, secondary epilepsy, and resolving croup. During hospitalization, a presumptive diagnosis of meningoencephalitis was made, which was later confirmed through clinical assessment and molecular detection of Human Herpesvirus 6 (HHV-6) in cerebrospinal fluid, using the FilmArray Meningitis/Encephalitis Panel. Although viral encephalitis caused by HHV-6 is typically associated with viral reactivation, in this case, it occurred in an immunocompetent patient, posing a diagnostic challenge in differentiating between the two forms. Early detection and appropriate treatment were crucial for the clinical resolution of this case, highlighting the importance of thorough diagnosis and precise identification of the causative agent to avoid misdiagnosis and improve clinical outcomes.
- 27 March 2025
- Published by Hospital Regional Lambayeque in Revista Experiencia en Medicina del Hospital Regional Lambayeque
- Vol. 11 (1)
Open AccessMeningoencefalitis por Herpesvirus Humano 6 (HHV-6) en un niño inmunocompetente de 2 años: Reporte de caso
A clinical case is presented of a 2-year and 5-month-old child who was admitted to the Hospital Regional Lambayeque in Chiclayo, Peru, with an initial diagnosis of status epilepticus, moderate dehydration, secondary epilepsy, and resolving croup. During hospitalization, a presumptive diagnosis of meningoencephalitis was made, which was later confirmed through clinical assessment and molecular detection of Human Herpesvirus 6 (HHV-6) in cerebrospinal fluid, using the FilmArray Meningitis/Encephalitis Panel. Although viral encephalitis caused by HHV-6 is typically associated with viral reactivation, in this case, it occurred in an immunocompetent patient, posing a diagnostic challenge in differentiating between the two forms. Early detection and appropriate treatment were crucial for the clinical resolution of this case, highlighting the importance of thorough diagnosis and precise identification of the causative agent to avoid misdiagnosis and improve clinical outcomes.
- Open Access
- 18 December 2023
- Published by Instituto Nacional de Salud (Peru) in Revista Peruana de Medicina Experimental Y Salud Pública
- Vol. 40 (4) , 493
Diferencias en el impacto del mayor brote epidémico de dengue en la historia del Perú y lecciones aprendidas
- 18 December 2023
- Published by Instituto Nacional de Salud (Peru) in Revista Peruana de Medicina Experimental Y Salud Pública
- Vol. 40 (4) , 493
Open AccessDiferencias en el impacto del mayor brote epidémico de dengue en la historia del Perú y lecciones aprendidas
- Open Access
- 31 October 2023
- Published by Elsevier in Journal of Infection and Public Health
- Vol. 16 (Suppl 1) , 52-60
Antibiotic point prevalence survey and antimicrobial resistance in hospitalized patients across Peruvian reference hospitals
- 31 October 2023
- Published by Elsevier in Journal of Infection and Public Health
- Vol. 16 (Suppl 1) , 52-60
Open AccessAntibiotic point prevalence survey and antimicrobial resistance in hospitalized patients across Peruvian reference hospitals
- Open Access
- 30 January 2021
- Published by Universidad del Valle in Colombia Medica
- Vol. 52 (1) , e7014577
Pityriasis rubra pilaris post-infection due COVID-19: case report
Case description: 32-month-old boy, IgG positive for SARS-CoV-2, presented to the emergency department with dermatologic lesions. Clinical findings: Four days before admission, he presented skin eruptions with redness and pruritus on hands and feet. Generalized papular erythema was evidenced, upper extremities with diffuse erythematosquamous plaques, palmoplantar keratoderma, so he was evaluated by a dermatologist who diagnosed pityriasis rubra pilaris. Treatment and outcome: rehydrating cream, cetirizine 0.5 mg/kg/day every two days, and prednisolone 2 mg/kg/day in the morning. He was discharged after 14 days, the patient presented clinical improvement, but the erythematous lesion persisted on the trunk and extremities. In the evaluation, after three months, the patient did not show the described lesions, evidencing an improvement and clinical resolution of the dermatological problems. Clinical relevance: We report a patient with pityriasis rubra piloris associated with a post-infection by SARS-CoV-2 that had not been described before.
- 30 January 2021
- Published by Universidad del Valle in Colombia Medica
- Vol. 52 (1) , e7014577
Open AccessPityriasis rubra pilaris post-infection due COVID-19: case report
Case description: 32-month-old boy, IgG positive for SARS-CoV-2, presented to the emergency department with dermatologic lesions. Clinical findings: Four days before admission, he presented skin eruptions with redness and pruritus on hands and feet. Generalized papular erythema was evidenced, upper extremities with diffuse erythematosquamous plaques, palmoplantar keratoderma, so he was evaluated by a dermatologist who diagnosed pityriasis rubra pilaris. Treatment and outcome: rehydrating cream, cetirizine 0.5 mg/kg/day every two days, and prednisolone 2 mg/kg/day in the morning. He was discharged after 14 days, the patient presented clinical improvement, but the erythematous lesion persisted on the trunk and extremities. In the evaluation, after three months, the patient did not show the described lesions, evidencing an improvement and clinical resolution of the dermatological problems. Clinical relevance: We report a patient with pityriasis rubra piloris associated with a post-infection by SARS-CoV-2 that had not been described before.
- Open Access
- 13 October 2020
- Published by Hospital Regional Lambayeque in Revista Experiencia en Medicina del Hospital Regional Lambayeque
- Vol. 6 (3)
Antimicrobianos en COVID-19: parar ahora
- 13 October 2020
- Published by Hospital Regional Lambayeque in Revista Experiencia en Medicina del Hospital Regional Lambayeque
- Vol. 6 (3)
Open AccessAntimicrobianos en COVID-19: parar ahora